Overview

Managing Alcoholism in People Who Do Not Respond to Naltrexone

Status:
Completed
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
This is a study involving treatment for alcohol dependence (alcoholism). The study will combine motivational enhancement therapy and cognitive behavioral therapy (combined behavioral intervention, or CBI) and tests the benefits of continued/discontinued treatment with naltrexone in a randomized placebo-controlled trial. CBI may have advantages in motivating patients to greater medication adherence and may address psychosocial factors that may limit the effects of naltrexone.
Phase:
Phase 4
Details
Lead Sponsor:
University of Pennsylvania
Treatments:
Naltrexone